These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 19428072)

  • 1. Prevalence of erectile dysfunction in men screened for prostate cancer.
    Bianco FJ; McHone BR; Wagner K; King A; Burgess J; Patierno S; Jarrett TW
    Urology; 2009 Jul; 74(1):89-93. PubMed ID: 19428072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of erectile dysfunction among Brazilian men screened for prostate cancer.
    Paranhos M; Antunes A; Andrade E; Freire G; Srougi M
    BJU Int; 2009 Oct; 104(8):1130-3. PubMed ID: 19426190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower urinary tract symptoms and erectile dysfunction are highly prevalent in ageing men.
    Glina S; Santana AW; Azank F; Mello LF; Moreira ED
    BJU Int; 2006 Apr; 97(4):763-5. PubMed ID: 16536769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obstructive lower urinary tract symptoms correlate with erectile dysfunction.
    Elliott SP; Gulati M; Pasta DJ; Spitalny GM; Kane CJ; Yee R; Lue TF
    Urology; 2004 Jun; 63(6):1148-52. PubMed ID: 15183969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of sildenafil citrate treatment on serum dehydroepiandrosterone sulfate levels in patients with erectile dysfunction.
    Tekdogan U; Tuncel A; Tuglu D; Basar MM; Atan A
    Urology; 2006 Sep; 68(3):626-30. PubMed ID: 16979704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for erectile dysfunction as part of periodic examination programs--concept and implementation.
    Heruti RJ; Yossef M; Shochat T
    Int J Impot Res; 2004 Aug; 16(4):341-5. PubMed ID: 14961050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between lower urinary tract symptoms and erectile dysfunction in men presenting for prostate cancer screening.
    Reggio E; de Bessa J; Junqueira RG; Timm O; Sette MJ; Sansana V; Gomes CM
    Int J Impot Res; 2007; 19(5):492-5. PubMed ID: 17554395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for erectile dysfunction in the primary care practice: results of a survey.
    Hakim J; Subit M; Maroon M; Jacques CH; Zaslau S
    W V Med J; 2005; 101(2):67-70. PubMed ID: 16042090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depressive symptoms and erectile dysfunction in men with coronary artery disease.
    Mulat B; Arbel Y; Mashav N; Saar N; Steinvil A; Heruti R; Banai S; Justo D
    Urology; 2010 Jan; 75(1):104-7. PubMed ID: 19931891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An analysis of erectile function after intensity modulated radiation therapy for localized prostate carcinoma.
    Brown MW; Brooks JP; Albert PS; Poggi MM
    Prostate Cancer Prostatic Dis; 2007; 10(2):189-93. PubMed ID: 17189954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance.
    Fujita K; Landis P; McNeil BK; Pavlovich CP
    J Urol; 2009 Dec; 182(6):2664-9. PubMed ID: 19836757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patterns of sexual and erectile dysfunction and response to treatment in patients receiving androgen deprivation therapy for prostate cancer.
    DiBlasio CJ; Malcolm JB; Derweesh IH; Womack JH; Kincade MC; Mancini JG; Ogles ML; Lamar KD; Patterson AL; Wake RW
    BJU Int; 2008 Jul; 102(1):39-43. PubMed ID: 18294309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience.
    Cappelleri JC; Rosen RC
    Int J Impot Res; 2005; 17(4):307-19. PubMed ID: 15875061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational models for detection of erectile dysfunction.
    Wald M; Seftel AD; Ross LS; Mohamed MA; Niederberger CS
    J Urol; 2005 Jan; 173(1):167-70. PubMed ID: 15592067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drivers and barriers to seeking treatment for erectile dysfunction: a comparison of six countries.
    Shabsigh R; Perelman MA; Laumann EO; Lockhart DC
    BJU Int; 2004 Nov; 94(7):1055-65. PubMed ID: 15541128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ejaculatory disorders may affect screening for prostate cancer.
    Walz J; Perrotte P; Gallina A; Bénard F; Valiquette L; McCormack M; Montorsi F; Karakiewicz PI
    J Urol; 2007 Jul; 178(1):232-7; discussion 237-8. PubMed ID: 17499807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of finasteride and alpha-blockers as independent risk factors for erectile dysfunction.
    Sadeghi-Nejad H; Sherman N; Lue J
    Int J Clin Pract; 2003; 57(6):484-7. PubMed ID: 12918887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of validated instruments measuring sexual function in men.
    Levinson AW; Ward NT; Sanda MG; Mettee LZ; Wei JT; Su LM; Litwin MS; Pavlovich CP
    Urology; 2010 Aug; 76(2):380-6. PubMed ID: 20573377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for erectile dysfunction and associated cardiovascular risk factors in Israeli men.
    Heruti RJ; Steinvil A; Shochat T; Saar N; Mashav N; Arbel Y; Justo D
    Isr Med Assoc J; 2008 Oct; 10(10):686-90. PubMed ID: 19009946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.